Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years

References

• Bach C, Henriksen T, Bossi R, Bech B, Fuglsang J, Olsen J, Nohr E. 2015. Perfluoroalkyl acid concentrations in blood samples subjected to transportation and processing delay. PLoS One. 10:e0137768.
   PubMed Web of Science ®Google Scholar
• Capua T, Katz J, Bocchini J. 2013. Update on adolescent immunizations: Selected review of U.S. recommendations and literature. Curr Opin Pediatr. 25:397–406.
   PubMed Web of Science ®Google Scholar
• CDC (Centers for Disease Control). 2015. Fourth national report on human exposure to environmental chemicals. Atlanta (GA): Centers for Disease Control and Prevention.
   Google Scholar
• Choi A, Cordier S, Weihe P, Grandjean P. 2008. Negative confounding in the evaluation of toxicity: The case of methylmercury in fish and seafood. Crit Rev Toxicol. 38:877–893.
   PubMed Web of Science ®Google Scholar
• Corsini E, Sangiovanni E, Avogadro A, Galbiati V, Viviani B, Marinovich M, Galli C, Dell'Agli M, Germolec D. 2012. In vitro characterization of the immunotoxic potential of several perfluorinated compounds (PFCs). Toxicol Appl Pharmacol. 258:248–255.
   PubMed Web of Science ®Google Scholar
• Dalgard C, Petersen M, Steuerwald U, Weihe P, Grandjean P. 2016. Umbilical cord serum 25-hydroxyvitamin D concentrations and relation to birthweight, head circumference and infant length at age 14 days. Paediatr Perinat Epidemiol. 30:238–245.
   PubMed Web of Science ®Google Scholar
• Dalsager L, Christensen N, Husby S, Kyhl H, Nielsen F, Høst A, Grandjean P, Jensen T. 2016. Association between prenatal exposure to perfluorinated compounds and symptoms of infections at age 1–4 years among 359 children in the Odense Child Cohort. Environ Int. 96:58–64.
   PubMed Web of Science ®Google Scholar
• Dietert R, DeWitt J. 2010. Developmental immunotoxicity (DIT): The why, when, and how of DIT testing. Methods Mol Biol. 598:17–25.
   PubMedGoogle Scholar
• Dietert R. 2014. Developmental immunotoxicity, perinatal programming, and non-communicable diseases: Focus on human studies. Adv Med. 2014:867805.
   PubMedGoogle Scholar
• Dong G, Liu M, Wang D, Zheng L, Liang Z, Jin Y. 2011. Sub-chronic effect of perfluoro-octanesulfonate (PFOS) on the balance of Type 1 and Type 2 cytokines in adult C57Bl/6 mice. Arch Toxicol. 85:1235–1244.
   PubMed Web of Science ®Google Scholar
• Dong G, Tung K, Tsai C, Liu M, Wang D, Liu W, Jin Y, Hsieh W, Lee Y, Chen P. 2013. Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of Taiwanese children. Environ Health Perspect. 121:507–513.
   PubMed Web of Science ®Google Scholar
• Eriksson U, Karrman A, Rotander A, Mikkelsen B, Dam M. 2013. Perfluoroalkyl substances (PFASs) in food and water from Faroe Islands. Environ Sci Pollut Res Int. 20:7940–7948.
   PubMed Web of Science ®Google Scholar
• Fei C, McLaughlin J, Lipworth L, Olsen J. 2010. Prenatal exposure to PFOA and PFOS and risk of hospitalization for infectious diseases in early childhood. Environ Res. 110:773–777.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Andersen E, Budtz-Jorgensen E, Nielsen F, Mølbak K, Weihe P, Heilmann C. 2012. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds. JAMA. 307:391–397.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Budtz-Jorgensen E. 2010. An ignored risk factor in toxicology: The total imprecision of exposure assessment. Pure Appl Chem. 82:383–391.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Budtz-Jorgensen E. 2013. Immunotoxicity of perfluorinated alkylates: Calculation of benchmark doses based on serum concentrations in children. Environ Health. 12:35.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen U, Budtz-Jørgensen E. 2017. Serum vaccine antibody concentrations in adolescents exposed to perfluorinated compounds. Environ Health Perspect. 125:077018.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Jensen A. 2004. Breastfeeding and the weanling's dilemma. Am J Public Health. 94:1075.
   PubMed Web of Science ®Google Scholar
• Grandjean P, Poulsen L, Heilmann C, Steuerwald U, Weihe P. 2010. Allergy and sensitization during childhood associated with prenatal and lactational exposure to marine pollutants. Environ Health Perspect. 118:1429–1433.
   PubMed Web of Science ®Google Scholar
• Granum B, Haug L, Namork E, Stølevik S, Thomsen C, Aaberge I, van Loveren H, Løvik M, Nygaard U. 2013. Pre-natal exposure to perfluoroalkyl substances may be associated with altered vaccine antibody levels and immune-related health outcomes in early childhood. J Immunotoxicol. 10:373–379.
   PubMed Web of Science ®Google Scholar
• Haug L, Thomsen C, Becher G. 2009. A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring. J Chromatogr. 1216:385–393.
   PubMed Web of Science ®Google Scholar
• Heilmann C, Budtz-Jorgensen E, Nielsen F, Heinzow B, Weihe P, Grandjean P. 2010. Serum concentrations of antibodies against vaccine toxoids in children exposed perinatally to immunotoxicants. Environ Health Perspect. 118:1434–1438.
   PubMed Web of Science ®Google Scholar
• Hendriksen C, Gun J, Nagel J, Kreeftenberg J. 1988. The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera. J Biol Stand. 16:287–297.
   PubMedGoogle Scholar
• Humblet O, Diaz-Ramirez L, Balmes J, Pinney S, Hiatt R. 2014. Perfluoroalkyl chemicals and asthma among children 12–19 years of age: NHANES (1999–2008). Environ Health Perspect. 122:1129–1133.
   PubMed Web of Science ®Google Scholar
• Kato K, Calafat A, Wong L, Wanigatunga A, Caudill S, Needham L. 2009. Poly-fluoroalkyl compounds in pooled sera from children participating in the National Health and Nutrition Examination Survey 2001–2002. Environ Sci Technol. 43:2641–2647.
   PubMed Web of Science ®Google Scholar
• Kielsen K, Shamim Z, Ryder L, Nielsen F, Grandjean P, Budtz-Jørgensen E, Heilmann C. 2016. Antibody response to booster vaccination with tetanus and diphtheria in adults exposed to perfluorinated alkylates. J Immunotoxicol. 13:270–273.
   PubMed Web of Science ®Google Scholar
• Kim B, Choi A, Ha E, Pedersen L, Nielsen F, Weihe P, Hong YC, Budtz-Jørgensen E, Grandjean P. 2014. Effect of hemoglobin adjustment on the precision of mercury concentrations in maternal and cord blood. Environ Res. 132:407–412.
   PubMed Web of Science ®Google Scholar
• Kramer M, Matush L, Vanilovich I, Platt R, Bogdanovich N, Sevkovskaya Z, Dzikovich I, Shishko G, Mazer B, Promotion of Breastfeeding Intervention Trial (PROBIT) Study Group, 2007. Effect of prolonged and exclusive breast feeding on risk of allergy and asthma: Cluster randomised trial. BMJ. 335:815.
   PubMed Web of Science ®Google Scholar
• Lindstrom A, Strynar M, Libelo E. 2011. Polyfluorinated compounds: Past, present, and future. Environ Sci Technol. 45:7954–7961.
   PubMed Web of Science ®Google Scholar
• Liu J, Li J, Liu Y, Chan H, Zhao Y, Cai Z, Wu Y. 2011. Comparison on gestation and lactation exposure of perfluorinated compounds for newborns. Environ Int. 37:1206–1212.
   PubMed Web of Science ®Google Scholar
• Ljungman P. 2013. Vaccination of immunocompromised hosts. In: Plotkin S, Offit P, editors. Vaccines. 6th ed. Amsterdam: Elsevier; p. 1243–1256.
   Google Scholar
• Looker C, Luster M, Calafat A, Johnson V, Burleson G, Burleson F, Fletcher T. 2014. Influenza vaccine response in adults exposed to perfluorooctanoate and perfluorooctanesulfonate. Toxicol Sci. 138:76–88.
   PubMed Web of Science ®Google Scholar
• Miyamura K, Nishio S, Ito A, Kono R. 1974. Micro-cell culture method for determination of diphtheria toxin and anti-toxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration. J Biol Stand. 2:189–201.
   PubMedGoogle Scholar
• Mogensen U, Grandjean P, Heilmann C, Nielsen F, Weihe P, Budtz-Jørgensen E. 2015a. Structural equation modeling of immunotoxicity associated with exposure to perfluorinated alkylates. Environ Health. 14:47.
   PubMed Web of Science ®Google Scholar
• Mogensen U, Grandjean P, Nielsen F, Weihe P, Budtz-Jørgensen E. 2015b. Breastfeeding as an exposure pathway for perfluorinated alkylates. Environ Sci Technol. 49:10466–10473.
   PubMed Web of Science ®Google Scholar
• Mondal D, Weldon R, Armstrong B, Gibson L, Lopez-Espinosa M, Shin H, Fletcher T. 2014. Breastfeeding: A potential excretion route for mothers and implications for infant exposure to perfluoroalkyl acids. Environ Health Perspect. 122:187–192.
   PubMed Web of Science ®Google Scholar
• National Toxicology Program (NTP). 2016. Immunotoxicity associated with exposure to perfluorooctanoic acid (PFOA) or perfluorooctane sulfonate (PFOS); [accessed 2017 May 17]. http://ntp.niehs.nih.gov/pubhealth/hat/noms/pfoa/index.html.
   Google Scholar
• Pennings J, Jennen D, Nygaard U, Namork E, Haug L, van Loveren H, Granum B. 2016. Cord blood gene expression supports that prenatal exposure to perfluoroalkyl substances causes depressed immune functionality in early childhood. J Immunotoxicol. 13:173–180.
   PubMed Web of Science ®Google Scholar
• Romagnani S. 2014. T cell subpopulations. Chem Immunol Allergy. 100:155–164.
   PubMedGoogle Scholar
• Schatz D, Ellis T, Ottendorfer E, Jodoin E, Barrett D, Atkinson M. 1998. Aging and the immune response to tetanus toxoid: Diminished frequency and level of cellular immune reactivity to antigenic stimulation. Clin Diagn Lab Immunol. 5:894–896.
   PubMedGoogle Scholar
• Seals R, Bartell S, Steenland K. 2011. Accumulation and clearance of perfluorooctanoic acid (PFOA) in current and former residents of an exposed community. Environ Health Perspect. 119:119–124.
   PubMed Web of Science ®Google Scholar
• Stefanidou M, Maravelias C, Spiliopoulou C. 2009. Human exposure to endocrine disruptors and breast milk. Endocr Metab Immune Disord Drug Targets. 9:269–276.
   PubMedGoogle Scholar
• Timmermann C, Budtz-Jorgensen E, Jensen T, Osuna C, Petersen M, Steuerwald U, Nielsen F, Poulsen L, Weihe P, Grandjean P. 2017. Association between perfluoroalkyl substance exposure and asthma and allergic disease in children as modified by MMR vaccination. J Immunotoxicol. 14:39–49.
   PubMed Web of Science ®Google Scholar
• van Loveren H, Germolec D, Koren H, Luster M, Nolan C, Repetto R, Smith E, Vos J, Vogt R. 1999. Report of the Bilthoven Symposium: Advancement of epidemiological studies in assessing the human health effects of immunotoxic agents in the environment and the workplace. Biomarkers. 4:135–157.
   PubMedGoogle Scholar
• Verner M, Ngueta G, Jensen E, Fromme H, Völkel W, Nygaard U, Granum B, Longnecker M. 2016. A simple pharmacokinetic model of prenatal and postnatal exposure to perfluoroalkyl substances (PFASs). Environ Sci Technol. 50:978–986.
   PubMed Web of Science ®Google Scholar
• Weihe P, Kato K, Calafat A, Nielsen F, Wanigatunga A, Needham L, Grandjean P. 2008. Serum concentrations of polyfluoroalkyl compounds in Faroese whale meat consumers. Environ Sci Technol. 42:6291–6295.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Beesoon S, Zhu L, Martin J. 2013. Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life. Environ Sci Technol. 47:10619–10627.
   PubMed Web of Science ®Google Scholar